| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | myosin filament | 3.10e-05 | 25 | 153 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 4.93e-05 | 28 | 153 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 7.16e-05 | 59 | 153 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | muscle myosin complex | 2.01e-04 | 16 | 153 | 3 | GO:0005859 | |
| Domain | Myosin-like_IQ_dom | 1.45e-05 | 19 | 151 | 4 | IPR027401 | |
| Domain | - | 1.45e-05 | 19 | 151 | 4 | 4.10.270.10 | |
| Domain | DDI1_N | 6.49e-05 | 2 | 151 | 2 | IPR033882 | |
| Domain | PROTEIN_KINASE_ATP | ERBB3 VRK1 MYLK TRIO KALRN MARK3 SPEG SRPK2 ZAP70 BMPR1A IGF1R ULK4 WEE2 | 9.30e-05 | 459 | 151 | 13 | PS00107 |
| Domain | Kinase-like_dom | SMG1 ERBB3 VRK1 MYLK TRIO KALRN MARK3 SPEG SRPK2 ZAP70 BMPR1A IGF1R ULK4 WEE2 | 1.32e-04 | 542 | 151 | 14 | IPR011009 |
| Domain | Prot_kinase_dom | ERBB3 VRK1 MYLK TRIO KALRN MARK3 SPEG SRPK2 ZAP70 BMPR1A IGF1R ULK4 WEE2 | 1.74e-04 | 489 | 151 | 13 | IPR000719 |
| Domain | PLAC | 1.77e-04 | 14 | 151 | 3 | PF08686 | |
| Domain | PROTEIN_KINASE_DOM | ERBB3 VRK1 MYLK TRIO KALRN MARK3 SPEG SRPK2 ZAP70 BMPR1A IGF1R ULK4 WEE2 | 1.88e-04 | 493 | 151 | 13 | PS50011 |
| Domain | Myosin_N | 2.19e-04 | 15 | 151 | 3 | PF02736 | |
| Domain | Myosin_N | 2.19e-04 | 15 | 151 | 3 | IPR004009 | |
| Domain | Myosin_head_motor_dom | 2.45e-04 | 38 | 151 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.45e-04 | 38 | 151 | 4 | PS51456 | |
| Domain | Myosin_head | 2.45e-04 | 38 | 151 | 4 | PF00063 | |
| Domain | MYSc | 2.45e-04 | 38 | 151 | 4 | SM00242 | |
| Domain | Myosin_tail_1 | 3.87e-04 | 18 | 151 | 3 | PF01576 | |
| Domain | Myosin_tail | 3.87e-04 | 18 | 151 | 3 | IPR002928 | |
| Domain | ARM-type_fold | 4.44e-04 | 339 | 151 | 10 | IPR016024 | |
| Domain | PLAC | 4.56e-04 | 19 | 151 | 3 | PS50900 | |
| Domain | PLAC | 4.56e-04 | 19 | 151 | 3 | IPR010909 | |
| Domain | Asp_protease | 6.39e-04 | 5 | 151 | 2 | PF09668 | |
| Domain | Peptidase_aspartic_DDI1-type | 6.39e-04 | 5 | 151 | 2 | IPR019103 | |
| Domain | Somatotropin_CS | 6.39e-04 | 5 | 151 | 2 | IPR018116 | |
| Domain | PROTEIN_KINASE_ST | 7.38e-04 | 362 | 151 | 10 | PS00108 | |
| Domain | Peptidase_M12B_ADAM-TS | 9.26e-04 | 24 | 151 | 3 | IPR013273 | |
| Domain | SOMATOTROPIN_2 | 9.53e-04 | 6 | 151 | 2 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 9.53e-04 | 6 | 151 | 2 | PS00266 | |
| Domain | Hormone_1 | 9.53e-04 | 6 | 151 | 2 | PF00103 | |
| Domain | Protein_kinase_ATP_BS | 1.05e-03 | 379 | 151 | 10 | IPR017441 | |
| Domain | - | 1.09e-03 | 56 | 151 | 4 | 3.50.50.60 | |
| Domain | Pkinase | 1.09e-03 | 381 | 151 | 10 | PF00069 | |
| Domain | FAD/NAD-binding_dom | 1.16e-03 | 57 | 151 | 4 | IPR023753 | |
| Domain | Somatotropin | 1.33e-03 | 7 | 151 | 2 | IPR001400 | |
| Domain | Recep_L_domain | 1.33e-03 | 7 | 151 | 2 | PF01030 | |
| Domain | Furin-like | 1.33e-03 | 7 | 151 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 1.33e-03 | 7 | 151 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 1.33e-03 | 7 | 151 | 2 | IPR006211 | |
| Domain | - | 1.33e-03 | 7 | 151 | 2 | 3.80.20.20 | |
| Domain | ARM-like | 1.61e-03 | 270 | 151 | 8 | IPR011989 | |
| Domain | DH_1 | 1.69e-03 | 63 | 151 | 4 | PS00741 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH4 DSC1 NUP85 COPA MARK3 KRT35 IARS1 PSMA6 NUP88 KRI1 SHMT2 HUWE1 DIS3 DHX8 IVNS1ABP LRPPRC KLHL9 CTPS2 KLHL42 DDX23 ABCC12 EIF3D USP15 EIF3M KRT36 NIN | 5.63e-13 | 1005 | 156 | 26 | 19615732 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH4 MARK3 KRT35 IARS1 PSMA6 NELFB SHMT2 XPO4 SPIRE1 SRPK2 RB1CC1 PRKRA GH1 LRPPRC IGF1R TIAM1 FDFT1 EIF4EBP1 DDX23 EIF3D USP15 PREX1 EIF3M KRT36 DYNC1H1 | 6.68e-10 | 1284 | 156 | 25 | 17353931 |
| Pubmed | THOC1 GPD2 DCAKD SMG1 NUP85 COPA MARK3 ST7 PSMA6 VPS8 KRI1 SHMT2 XPO4 NCBP1 HUWE1 DIS3 PRKRA LRPPRC NOP58 FDFT1 DDX23 MICAL3 EIF3D EIF3M DYNC1H1 HSP90AA1 | 1.43e-09 | 1440 | 156 | 26 | 30833792 | |
| Pubmed | GPD2 DCAKD DNAJC13 COPA TRIO ST7 KRI1 SHMT2 XPO4 NCBP1 HUWE1 RB1CC1 ITGA5 ANKLE2 PTPN7 TIAM1 PTPRK FDFT1 SBF2 MICAL3 HSP90AA1 NIN | 2.06e-09 | 1049 | 156 | 22 | 27880917 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | THOC1 GPD2 VRK1 DSC1 COPA TRIO IARS1 PSMA6 NUP88 KRI1 SHMT2 DUOX2 NCBP1 HUWE1 DIS3 DHX8 IVNS1ABP LRPPRC NOP58 RBPJ EIF3D MYO18B NIPBL EIF3M DYNC1H1 | 5.46e-09 | 1425 | 156 | 25 | 30948266 |
| Pubmed | SMG1 MYH1 MYH3 MYH4 STIM2 FOXRED1 MYLK NUP85 ACACB COPA PSMA6 DUOX2 NCBP1 FNBP1L STOX1 PDE10A ANKLE2 KRT73 CCDC148 LRPPRC BMPR1A DDX23 PREX1 NIPBL HSP90AA1 | 6.92e-09 | 1442 | 156 | 25 | 35575683 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAKD HAUS6 GRIPAP1 DNAJC13 IFT20 IARS1 NUP88 SHMT2 XPO4 SPIRE1 ANKLE2 DIS3 IVNS1ABP LRPPRC TIAM1 C3 KATNIP EIF3D USP15 EIF3M DYNC1H1 HSP90AB3P | 1.23e-07 | 1321 | 156 | 22 | 27173435 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GPD2 GRIPAP1 VRK1 DNAJC13 DSC1 COPA IARS1 PSMA6 SHMT2 NCBP1 FNBP1L HUWE1 DIS3 PRKRA LRPPRC NOP58 SPATS2L FDFT1 DHRS7 EIF3D EIF3M HSP90AA1 | 2.21e-07 | 1367 | 156 | 22 | 32687490 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | OR51A4 MYH1 MYH3 MYH4 IARS1 NELFB DDI2 NCBP1 SLC28A3 HUWE1 STOX1 IVNS1ABP MCM3AP EIF3D DYNC1H1 FBXO34 | 2.34e-07 | 736 | 156 | 16 | 29676528 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH3 MYH4 DSC1 COPA IARS1 PSMA6 XPO4 NCBP1 HUWE1 LRPPRC IL1R2 C3 EIF3M DYNC1H1 | 2.53e-07 | 647 | 156 | 15 | 26618866 |
| Pubmed | COPA NUP88 KRI1 NCBP1 HUWE1 DIS3 DHX8 PRKRA LRPPRC NOP58 MCM3AP DDX23 EIF3D NIPBL DYNC1H1 | 2.85e-07 | 653 | 156 | 15 | 22586326 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HAUS6 GRIPAP1 ACACB TRIO ST7 NUP88 KRI1 SHMT2 ACE ANKLE2 KLHL9 MICAL3 MGA USP15 DYNC1H1 HSP90AA1 NIN | 3.26e-07 | 853 | 156 | 17 | 28718761 |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 1985022 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 3.53e-07 | 4 | 156 | 3 | 11029314 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 12547197 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | THOC1 GPD2 VRK1 DNAJC13 COPA KALRN SHMT2 NCBP1 USP9Y DHX8 PRKRA LRPPRC NOP58 DHRS7 DDX23 EIF3D NIPBL DYNC1H1 HSP90AA1 | 4.36e-07 | 1082 | 156 | 19 | 38697112 |
| Pubmed | 5.03e-07 | 105 | 156 | 7 | 9628581 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | VRK1 FOXRED1 NUP85 ACACB COPA IARS1 PSMA6 KRI1 SHMT2 NCBP1 HUWE1 DIS3 LRPPRC NOP58 FDFT1 DDX23 EIF3D NIPBL EIF3M DYNC1H1 HSP90AA1 | 5.03e-07 | 1318 | 156 | 21 | 30463901 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | TRIO IFT20 IARS1 PSMA6 KRI1 SRPK2 HUWE1 RB1CC1 BMPR1A RBPJ DYNC1H1 | 7.26e-07 | 358 | 156 | 11 | 32460013 |
| Pubmed | THOC1 COPA MARK3 IARS1 SHMT2 SRPK2 NCBP1 HUWE1 DIS3 DHX8 PRKRA LRPPRC BMPR1A NOP58 IGF1R EIF3D MGA USP15 DYNC1H1 HSP90AA1 | 8.70e-07 | 1247 | 156 | 20 | 27684187 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 8.79e-07 | 5 | 156 | 3 | 3829126 | |
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 6196357 | ||
| Pubmed | FOXRED1 IARS1 PSMA6 SHMT2 HUWE1 RB1CC1 DIS3 IVNS1ABP LRPPRC DDX23 EIF3D MGA HSP90AA1 | 1.36e-06 | 551 | 156 | 13 | 34728620 | |
| Pubmed | ERBB3 FOXRED1 COPA TRIO KALRN LRSAM1 SRPK2 NCBP1 HUWE1 USP9Y PRKRA TIAM1 PTPRK GPSM2 SPRED1 EIF3D PREX1 NIPBL DYNC1H1 HSP90AA1 | 1.38e-06 | 1285 | 156 | 20 | 35914814 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GPD2 COPA IARS1 NELFB KRI1 SHMT2 SRPK2 NCBP1 FNBP1L HUWE1 DIS3 DHX8 LRPPRC NOP58 CTPS2 DDX23 EIF3D NIPBL EIF3M DYNC1H1 HSP90AA1 | 1.56e-06 | 1415 | 156 | 21 | 28515276 |
| Pubmed | NUP85 COPA IARS1 XPO4 NCBP1 SYS1 HUWE1 IVNS1ABP LRPPRC FDFT1 MGA USP15 EIF3M HSP90AA1 | 1.74e-06 | 657 | 156 | 14 | 36180527 | |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.75e-06 | 6 | 156 | 3 | 10077619 | |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 26762506 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.75e-06 | 6 | 156 | 3 | 10588881 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | COPA IARS1 PSMA6 HUWE1 IVNS1ABP LRPPRC CHCHD4 KLHL9 KLHL42 EIF3D USP15 HSP90AA1 | 2.67e-06 | 495 | 156 | 12 | 28581483 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | THOC1 SMG1 MYH3 NUP85 KRI1 SRPK2 KRT73 NOP58 EIF3D MGA NIPBL | 2.70e-06 | 410 | 156 | 11 | 26949251 |
| Pubmed | THOC1 DSC1 COPA IARS1 PSMA6 SHMT2 NCBP1 HUWE1 DHX8 LRPPRC NOP58 DDX23 EIF3D EIF3M DYNC1H1 | 2.83e-06 | 786 | 156 | 15 | 29128334 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DNAJC13 DSC1 COPA IARS1 LRSAM1 PSMA6 SHMT2 HUWE1 DIS3 PRKRA LRPPRC NOP58 MCM3AP DDX23 EIF3D MGA NIPBL EIF3M DYNC1H1 HSP90AA1 | 3.01e-06 | 1353 | 156 | 20 | 29467282 |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 20403354 | ||
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 17698843 | ||
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 21990313 | ||
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 35210422 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 3.06e-06 | 7 | 156 | 3 | 29758057 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 16819597 | ||
| Pubmed | 3.51e-06 | 266 | 156 | 9 | 19380743 | ||
| Pubmed | The sperm-associated antigen 6 interactome and its role in spermatogenesis. | 3.51e-06 | 199 | 156 | 8 | 31146259 | |
| Pubmed | DNAJC13 COPA IARS1 SRPK2 DIS3 PRKRA LRPPRC NOP58 SPATS2L SBF2 C3 EIF3D DYNC1H1 | 3.52e-06 | 601 | 156 | 13 | 33658012 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | THOC1 GPD2 NUP85 COPA IARS1 SHMT2 NCBP1 HUWE1 RB1CC1 DHX8 LRPPRC NOP58 DDX23 EIF3D MGA NIPBL DYNC1H1 | 3.89e-06 | 1024 | 156 | 17 | 24711643 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | THOC1 DSC1 NUP85 COPA MARK3 IARS1 KRI1 SRPK2 NCBP1 DHX8 PRKRA LRPPRC NOP58 SPATS2L C3 EIF3D EIF3M DYNC1H1 HSP90AA1 | 3.94e-06 | 1257 | 156 | 19 | 36526897 |
| Pubmed | 4.19e-06 | 144 | 156 | 7 | 35681168 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HAUS6 NUP85 COPA IFT20 NUP88 TUBGCP6 CHCHD4 BMPR1A NOP58 FBXO28 KLHL42 DDX23 MICAL3 EIF3D NIPBL EIF3M DYNC1H1 HSP90AA1 | 4.76e-06 | 1155 | 156 | 18 | 20360068 |
| Pubmed | 4.88e-06 | 8 | 156 | 3 | 25936582 | ||
| Pubmed | 4.88e-06 | 8 | 156 | 3 | 3864153 | ||
| Pubmed | 4.88e-06 | 8 | 156 | 3 | 36200826 | ||
| Pubmed | HAUS6 COPA IARS1 PSMA6 DDI2 HUWE1 DIS3 PRKRA LRPPRC EIF3D DYNC1H1 HSP90AA1 | 5.77e-06 | 534 | 156 | 12 | 35032548 | |
| Pubmed | DNAJC13 NUP85 COPA IARS1 NELFB NCBP1 HUWE1 DIS3 LRPPRC NOP58 EIF3D DYNC1H1 HSP90AA1 | 6.70e-06 | 638 | 156 | 13 | 33239621 | |
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 24759003 | ||
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 15044591 | ||
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 1358809 | ||
| Pubmed | 8.37e-06 | 224 | 156 | 8 | 32941674 | ||
| Pubmed | 8.64e-06 | 225 | 156 | 8 | 25277244 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GRIPAP1 NUP85 COPA IARS1 LRSAM1 PSMA6 NUP88 NELFB SHMT2 DDI2 NCBP1 HUWE1 DIS3 IVNS1ABP CTPS2 EIF3D USP15 EIF3M DYNC1H1 HSP90AA1 | 8.80e-06 | 1455 | 156 | 20 | 22863883 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | DNAJC13 DSC1 IARS1 PSMA6 IVNS1ABP SPATS2L EIF3D MGA USP15 EIF3M DYNC1H1 HSP90AA1 | 8.97e-06 | 558 | 156 | 12 | 27591049 |
| Pubmed | GPD2 HAUS6 NUP85 COPA NUP88 NELFB SHMT2 DHX8 LRPPRC FDFT1 DDX23 DYNC1H1 | 9.30e-06 | 560 | 156 | 12 | 35241646 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DCAKD DNAJC13 TRIO MARK3 ST7 FBXL17 SPIRE1 SRPK2 FNBP1L HUWE1 PDE10A LRPPRC KLHL9 CMIP IGF1R SBF2 KATNIP MICAL3 USP15 EIF3M | 1.23e-05 | 1489 | 156 | 20 | 28611215 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | VRK1 DNAJC13 COPA NCBP1 HUWE1 DHX8 GNA14 DDX23 DEPDC7 NIPBL DYNC1H1 HSP90AA1 | 1.36e-05 | 582 | 156 | 12 | 20467437 |
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.42e-05 | 11 | 156 | 3 | 16024798 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DSC1 NUP85 COPA IARS1 PSMA6 SHMT2 NCBP1 HUWE1 DIS3 LRPPRC NOP58 KLHL9 CTPS2 FDFT1 DDX23 USP15 DYNC1H1 HSP90AA1 | 1.49e-05 | 1257 | 156 | 18 | 37317656 |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.50e-05 | 175 | 156 | 7 | 25756610 | |
| Pubmed | SMG1 MYH3 TRIO KALRN IVNS1ABP LRPPRC FDFT1 SPRED1 MYO18B MGA HSP90AA1 | 1.65e-05 | 497 | 156 | 11 | 23414517 | |
| Pubmed | MARK3 SPEG VPS8 EPM2AIP1 FBXO28 MCM3AP KATNIP MICAL3 USP15 DYNC1H1 | 1.66e-05 | 407 | 156 | 10 | 12693553 | |
| Pubmed | COPA PSMA6 HUWE1 IVNS1ABP LRPPRC FDFT1 MGA USP15 EIF3M HSP90AA1 | 1.70e-05 | 408 | 156 | 10 | 33766124 | |
| Pubmed | COPA KRT35 IARS1 PSMA6 KRI1 NCBP1 USP9Y KRT73 LRPPRC NOP58 FDFT1 EIF3D EIF3M KRT36 DYNC1H1 HSP90AA1 HSP90AB3P | 1.81e-05 | 1153 | 156 | 17 | 29845934 | |
| Pubmed | 1.87e-05 | 72 | 156 | 5 | 36376293 | ||
| Pubmed | H19X-encoded miR-322(424)/miR-503 regulates muscle mass by targeting translation initiation factors. | 1.89e-05 | 12 | 156 | 3 | 34704401 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | VRK1 COPA NUP88 NELFB SHMT2 HUWE1 DHX8 PRKRA NOP58 CTPS2 EIF3D NIPBL DYNC1H1 | 1.89e-05 | 704 | 156 | 13 | 29955894 |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18425142 | ||
| Pubmed | Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer. | 2.00e-05 | 2 | 156 | 2 | 31728045 | |
| Pubmed | Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemia. | 2.00e-05 | 2 | 156 | 2 | 16300468 | |
| Pubmed | Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway. | 2.00e-05 | 2 | 156 | 2 | 34666670 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 2.00e-05 | 2 | 156 | 2 | 9382868 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 11150240 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 21372220 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25543140 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 15972449 | ||
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 2.00e-05 | 2 | 156 | 2 | 26858404 | |
| Pubmed | The human growth hormone gene family: structure and evolution of the chromosomal locus. | 2.00e-05 | 2 | 156 | 2 | 6306568 | |
| Pubmed | Molecular cloning and characterization of a novel nuclear protein kinase in mice. | 2.00e-05 | 2 | 156 | 2 | 9521809 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 23792093 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 14671660 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 17496728 | ||
| Pubmed | Intermolecular relations between the glucocorticoid receptor, ZAP-70 kinase, and Hsp-90. | 2.00e-05 | 2 | 156 | 2 | 17222799 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24282274 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25359884 | ||
| Pubmed | Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells. | 2.00e-05 | 2 | 156 | 2 | 23899556 | |
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 2.00e-05 | 2 | 156 | 2 | 11744674 | |
| Pubmed | 2.06e-05 | 332 | 156 | 9 | 25693804 | ||
| Pubmed | MYLK COPA IARS1 FNBP1L PRKRA LRPPRC NOP58 SPATS2L FDFT1 C3 EIF3D EIF3M DYNC1H1 | 2.10e-05 | 711 | 156 | 13 | 33022573 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | IARS1 PSMA6 SHMT2 SRPK2 NCBP1 DIS3 DHX8 PRKRA NOP58 DDX23 EIF3D DYNC1H1 HSP90AA1 | 2.19e-05 | 714 | 156 | 13 | 28302793 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 2.19e-05 | 256 | 156 | 8 | 35777956 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 2.19e-05 | 256 | 156 | 8 | 32698014 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 2.45e-05 | 13 | 156 | 3 | 8404542 | |
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 2.46e-05 | 189 | 156 | 7 | 29449217 | |
| Pubmed | THOC1 TSNAXIP1 GIMAP4 SRPK2 DHX8 PRKRA NOP58 SPATS2L DDX23 HFM1 EIF3D HSP90AA1 NIN | 2.49e-05 | 723 | 156 | 13 | 34133714 | |
| Interaction | CD274 interactions | VRK1 DSC1 NUP85 COPA NELFB SHMT2 XPO4 HUWE1 DIS3 LRPPRC FDFT1 CD274 EIF3D | 4.03e-06 | 369 | 150 | 13 | int:CD274 |
| Interaction | ADRM1 interactions | GRIPAP1 PSMA6 DDI2 NCBP1 DDI1 HUWE1 LRPPRC INSIG2 USP15 DYNC1H1 HSP90AA1 | 5.09e-06 | 266 | 150 | 11 | int:ADRM1 |
| Interaction | ASAH2 interactions | 7.95e-06 | 6 | 150 | 3 | int:ASAH2 | |
| Interaction | GRK7 interactions | 3.30e-05 | 25 | 150 | 4 | int:GRK7 | |
| Interaction | RIT1 interactions | THOC1 SMG1 HAUS6 NUP85 COPA IARS1 POLE2 PSMA6 NUP88 NELFB SRPK2 NCBP1 SYS1 ANKLE2 DIS3 ZAP70 DHX8 LRPPRC CHCHD4 NOP58 IGF1R DDX23 NIPBL | 4.01e-05 | 1230 | 150 | 23 | int:RIT1 |
| Interaction | CCHCR1 interactions | 5.59e-05 | 229 | 150 | 9 | int:CCHCR1 | |
| Interaction | RUVBL2 interactions | SMG1 IKZF3 DDI2 NCBP1 HUWE1 LRPPRC BMPR1A NOP58 FDFT1 CD274 MGA USP15 NIPBL DYNC1H1 HSP90AA1 | 5.79e-05 | 616 | 150 | 15 | int:RUVBL2 |
| Interaction | NUAK2 interactions | 6.01e-05 | 56 | 150 | 5 | int:NUAK2 | |
| Interaction | CDK11A interactions | 6.20e-05 | 180 | 150 | 8 | int:CDK11A | |
| Interaction | PRMT1 interactions | THOC1 FOXRED1 IARS1 SPEG PSMA6 VPS8 FBXL17 SHMT2 HUWE1 RB1CC1 DIS3 IVNS1ABP LRPPRC PTPN7 DDX23 EIF3D MGA USP15 HSP90AA1 | 6.24e-05 | 929 | 150 | 19 | int:PRMT1 |
| Interaction | INSRR interactions | 6.88e-05 | 93 | 150 | 6 | int:INSRR | |
| Interaction | BCAP31 interactions | MYH1 MYH3 MYH4 STIM2 COPA ST7 SHMT2 HUWE1 ITGA5 ANKLE2 LRPPRC FDFT1 DHRS7 HSP90AA1 | 6.97e-05 | 554 | 150 | 14 | int:BCAP31 |
| Interaction | ATG101 interactions | 7.31e-05 | 94 | 150 | 6 | int:ATG101 | |
| GeneFamily | Myosin heavy chains | 1.45e-06 | 15 | 106 | 4 | 1098 | |
| GeneFamily | Growth hormone family | 5.03e-04 | 6 | 106 | 2 | 1175 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.08e-04 | 66 | 106 | 4 | 722 | |
| GeneFamily | Kelch like|BTB domain containing | 1.90e-03 | 42 | 106 | 3 | 617 | |
| GeneFamily | Olfactory receptors, family 51 | 2.18e-03 | 44 | 106 | 3 | 164 | |
| GeneFamily | Eukaryotic translation initiation factor 3 | 2.55e-03 | 13 | 106 | 2 | 1121 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.59e-03 | 161 | 106 | 5 | 593 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | VRK1 DNAJC13 TRIO MARK3 SRPK2 FNBP1L RB1CC1 TRAPPC8 ANKLE2 LRPPRC BMPR1A IGF1R TIAM1 PTPRK RBPJ MICAL3 USP15 NIPBL | 3.36e-06 | 856 | 155 | 18 | M4500 |
| Coexpression | PAL_PRMT5_TARGETS_UP | 3.70e-06 | 204 | 155 | 9 | M10688 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 4.69e-06 | 210 | 155 | 9 | MM1172 | |
| Coexpression | LEE_BMP2_TARGETS_DN | HAUS6 VRK1 FOXRED1 NUP85 IARS1 POLE2 NUP88 SHMT2 XPO4 DDI2 NCBP1 DIS3 LRPPRC CHCHD4 NOP58 TIAM1 HSP90AA1 NIN | 9.30e-06 | 922 | 155 | 18 | MM1068 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | GIMAP4 SMG1 HAUS6 STIM2 IKZF3 MARK3 KRI1 XPO4 HUWE1 RB1CC1 TRAPPC8 ANKLE2 ZAP70 IVNS1ABP PTPN7 DHRS7 RBPJ USP15 PREX1 NIPBL DYNC1H1 CLEC2B NIN | 2.35e-05 | 1492 | 155 | 23 | M40023 |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 2.45e-05 | 198 | 155 | 8 | M6109 | |
| Coexpression | LEE_BMP2_TARGETS_DN | HAUS6 VRK1 FOXRED1 NUP85 IARS1 POLE2 NUP88 SHMT2 XPO4 NCBP1 DIS3 LRPPRC CHCHD4 NOP58 TIAM1 HSP90AA1 NIN | 2.69e-05 | 904 | 155 | 17 | M2325 |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-08 | 186 | 154 | 9 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-08 | 186 | 154 | 9 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.13e-07 | 179 | 154 | 8 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-07 | 192 | 154 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 3.94e-07 | 194 | 154 | 8 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-06 | 185 | 154 | 7 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.78e-06 | 185 | 154 | 7 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 185 | 154 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.51e-06 | 190 | 154 | 7 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.51e-06 | 190 | 154 | 7 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.67e-06 | 191 | 154 | 7 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.83e-06 | 192 | 154 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.00e-06 | 193 | 154 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.36e-06 | 127 | 154 | 6 | 7c3f8c791567fff5d2f42c2c7d09c78ec6ca3afe | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-06 | 197 | 154 | 7 | d6eb843f5ee1b1ea54416ba6e987eefe86ca3216 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-06 | 198 | 154 | 7 | 5c82dad416938d5c460069796d808170e7dbc8d9 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-06 | 198 | 154 | 7 | f7aa809040fa9f5782b92eec1f289d690eb5c7bd | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | 893bb7c25ad7c6589a4c7c0364c2ace666e9b4be | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-05 | 142 | 154 | 6 | 85e573616e54d41391b4ad8c3d38e4ca92112673 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 149 | 154 | 6 | f4bee5fdaaa4a1917e403de90e5a62353006df24 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 166 | 154 | 6 | fb2cfbf1d0a0f1950dd24c08ba00ebd64b06ceb4 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.91e-05 | 171 | 154 | 6 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 173 | 154 | 6 | a2c1ef3f4d7e9f68fc77ee7c42a4727bdea5da94 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 173 | 154 | 6 | 4830136f1f1976e00ac9af9062a531ac42533041 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 173 | 154 | 6 | 0b79e2a4fd19d524c24b69a6b524ffc6affdabe5 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 175 | 154 | 6 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-05 | 178 | 154 | 6 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-05 | 179 | 154 | 6 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-05 | 179 | 154 | 6 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.00e-05 | 181 | 154 | 6 | 7fb3c1d29c542a3cea7fa654432d501d82df138f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.25e-05 | 183 | 154 | 6 | f142b320023eef00b48d4820c46214c9794d37e7 | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-05 | 185 | 154 | 6 | ea3ff0bd3f312bd2e93227ecf6ed577366aab3e0 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 186 | 154 | 6 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.80e-05 | 187 | 154 | 6 | c8278525b3e1d3f3f4defcaf109cce22dd2e157a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.94e-05 | 188 | 154 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.94e-05 | 188 | 154 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.94e-05 | 188 | 154 | 6 | b1ec7c45aedcc3d22cac898c6a3679e7f8b44c77 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.09e-05 | 189 | 154 | 6 | 99b01893da9f9f7c9528afaffad178285211738b | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.24e-05 | 190 | 154 | 6 | c8031df82c3662ce4140c850277987f7210e9bcd | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.24e-05 | 190 | 154 | 6 | 4240d52a465bc3f8016834b22a35c44ba2b0a9f4 | |
| ToppCell | NS-control-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.40e-05 | 191 | 154 | 6 | 27f2151da2f41015a979499f274ab1284a36189f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-05 | 191 | 154 | 6 | a467205078bec92562e4b6b1b2116b88f421e8ba | |
| ToppCell | control-Lymphoid-CTL|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.40e-05 | 191 | 154 | 6 | 8df23473e24cfa51c09986102ddd391ed0f0b9cc | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.55e-05 | 192 | 154 | 6 | fedff776812c3d040d295ac8c806296e4018b247 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.55e-05 | 192 | 154 | 6 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.72e-05 | 193 | 154 | 6 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.72e-05 | 193 | 154 | 6 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|tumor_Lung / Location, Cell class and cell subclass | 5.88e-05 | 194 | 154 | 6 | 21d789585b3085aeeae3bef595c6cc5ea1c3dc4f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.05e-05 | 195 | 154 | 6 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.05e-05 | 195 | 154 | 6 | 0c49d22c348aec6d8a1a976e7c88d0a3b48a4244 | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.23e-05 | 196 | 154 | 6 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.23e-05 | 196 | 154 | 6 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.23e-05 | 196 | 154 | 6 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 6.23e-05 | 196 | 154 | 6 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.40e-05 | 197 | 154 | 6 | 2ed92f942475db6836e48da3c6b8235eb8691c38 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.40e-05 | 197 | 154 | 6 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.40e-05 | 197 | 154 | 6 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-05 | 198 | 154 | 6 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | 18-Distal-Endothelial-Endothelial|Distal / Age, Tissue, Lineage and Cell class | 6.59e-05 | 198 | 154 | 6 | efd3af3c0b4ab29605331ecdcb7a52cba38e6028 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-05 | 198 | 154 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.59e-05 | 198 | 154 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | 18-Distal-Endothelial|Distal / Age, Tissue, Lineage and Cell class | 6.59e-05 | 198 | 154 | 6 | ee657a84928d54eb7a9a66c7acb19a7c119d6423 | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|COVID-19_Moderate / disease group, cell group and cell class | 6.77e-05 | 199 | 154 | 6 | adcaf9bd73933259dcf7983ca369a98e2f312d0b | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-05 | 199 | 154 | 6 | f53e0e4c34e6aec81ab07593aa11e045ba04df06 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-05 | 199 | 154 | 6 | 62936fb64b33f7ad671f9c610bed665f17d3145e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-05 | 199 | 154 | 6 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|COVID-19_Severe / disease group, cell group and cell class | 6.77e-05 | 199 | 154 | 6 | a16b961996291bd5958c3851b7fdd7b45c53e19b | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 6.77e-05 | 199 | 154 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.96e-05 | 200 | 154 | 6 | be9a43acc2f926b9433ab3f018b911b03896a924 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.96e-05 | 200 | 154 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.96e-05 | 200 | 154 | 6 | 02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(1)_24hpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 1.07e-04 | 71 | 154 | 4 | 6aa56b0daaeb5e0ae30619f9c6945c8e42899b27 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.35e-04 | 142 | 154 | 5 | eaf08a0dbacc9ebbd54e377922e76d8ba854dcb8 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.49e-04 | 145 | 154 | 5 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.75e-04 | 150 | 154 | 5 | 70ac8ae4b1683fb17278a8e4606f2fa0b94988c0 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 151 | 154 | 5 | 512f7f37ddc8dfa1906f7fff92b571929236c9ea | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 153 | 154 | 5 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 154 | 154 | 5 | b16f3139ce50e70a6a2377b1da7d7877b4000ea1 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 155 | 154 | 5 | 4ae91bc7dbb9f713a1f110c17834b1d89f1b28db | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 155 | 154 | 5 | fdcc8a475156329b3594d5ed22ba03538305327c | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 155 | 154 | 5 | 1fb49b48e34e740118908951e079ea2a9994ae4f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-04 | 160 | 154 | 5 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-04 | 160 | 154 | 5 | 6b0faaa371650563f585722f5b2fb319e124ec38 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-04 | 160 | 154 | 5 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 165 | 154 | 5 | 6708beb0e8094f30cf5cd812e6a67a6db004a580 | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.79e-04 | 166 | 154 | 5 | f8f8423423d72f0ea0266b59126abb27beb23094 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 167 | 154 | 5 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 167 | 154 | 5 | 38b1f052d663fa8f407c54bdd2060216f26feb0e | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 168 | 154 | 5 | 3611605114f6b668b44728d6563cd02389e106af | |
| ToppCell | facs-Marrow-Granulocytes-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 169 | 154 | 5 | ee1969755180df58d32904e2bb4192da9373d03e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 170 | 154 | 5 | 4fb4ce46e4fa2418238e264875209d7ebe844d82 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 171 | 154 | 5 | d322cc042a6f4b4aa8ef80ae977edbce9e266d48 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 171 | 154 | 5 | 4f2a83d8091f1fd29542d2e5add57fd482e921b5 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.29e-04 | 172 | 154 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-04 | 172 | 154 | 5 | 10090b4b40f0f6f07a514e86811cadeecdf21670 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.38e-04 | 173 | 154 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.38e-04 | 173 | 154 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-04 | 174 | 154 | 5 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.56e-04 | 175 | 154 | 5 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 175 | 154 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| Drug | purealin | 2.44e-06 | 58 | 152 | 6 | CID006419303 | |
| Drug | AC1L1IZ2 | MYH1 MYH3 MYH4 MYLK ZAP70 SOCS7 GH2 IGF1R MYO18B DYNC1H1 HSP90AA1 | 6.55e-06 | 304 | 152 | 11 | CID000004795 |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.42e-05 | 10 | 147 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.42e-05 | 10 | 147 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.42e-05 | 10 | 147 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.42e-05 | 10 | 147 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.42e-05 | 10 | 147 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.42e-05 | 10 | 147 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.42e-05 | 10 | 147 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.42e-05 | 10 | 147 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.68e-05 | 31 | 147 | 4 | C1335167 | |
| Disease | distal myopathy (implicated_via_orthology) | 2.58e-05 | 12 | 147 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.58e-05 | 12 | 147 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.34e-05 | 13 | 147 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.28e-05 | 15 | 147 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 7.52e-05 | 45 | 147 | 4 | C0278701 | |
| Disease | Arthrogryposis | 1.51e-04 | 21 | 147 | 3 | C0003886 | |
| Disease | urate measurement | DNAJC13 MARK3 SHMT2 FNBP1L NOP58 CMIP IGF1R SPATS2L SBF2 ADAMTS17 HFM1 MYO18B FBXO34 HSP90AB3P | 1.61e-04 | 895 | 147 | 14 | EFO_0004531 |
| Disease | marginal zone B-cell lymphoma, systemic lupus erythematosus | 2.44e-04 | 5 | 147 | 2 | EFO_1000630, MONDO_0007915 | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 2.44e-04 | 5 | 147 | 2 | DOID:0060872 (implicated_via_orthology) | |
| Disease | aortic valve disease (implicated_via_orthology) | 3.65e-04 | 6 | 147 | 2 | DOID:62 (implicated_via_orthology) | |
| Disease | brain disease (implicated_via_orthology) | 3.65e-04 | 6 | 147 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.43e-04 | 71 | 147 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 5.09e-04 | 7 | 147 | 2 | DOID:0060870 (implicated_via_orthology) | |
| Disease | eotaxin measurement | 6.97e-04 | 80 | 147 | 4 | EFO_0008122 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.97e-04 | 80 | 147 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | dipeptidase 2 measurement | 1.08e-03 | 10 | 147 | 2 | EFO_0801528 | |
| Disease | Charcot-Marie-Tooth disease | 1.21e-03 | 42 | 147 | 3 | cv:C0007959 | |
| Disease | Weight Gain | 1.72e-03 | 102 | 147 | 4 | C0043094 | |
| Disease | myopathy (implicated_via_orthology) | 1.78e-03 | 48 | 147 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | HIV Infections | 1.78e-03 | 103 | 147 | 4 | C0019693 | |
| Disease | HIV Coinfection | 1.78e-03 | 103 | 147 | 4 | C4505456 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.85e-03 | 13 | 147 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | breast milk measurement | 1.98e-03 | 106 | 147 | 4 | EFO_0009092 | |
| Disease | Abnormality of refraction | GPD2 SMG1 ADAMTSL1 DNAJC13 PLVAP BMPR1A IGF1R ZNF540 ULK4 NIN | 2.07e-03 | 673 | 147 | 10 | HP_0000539 |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 2.16e-03 | 14 | 147 | 2 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.16e-03 | 14 | 147 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | anemia (is_implicated_in) | 2.16e-03 | 14 | 147 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | monoclonal gammopathy | 2.36e-03 | 53 | 147 | 3 | EFO_0000203 | |
| Disease | lymphocyte count | GIMAP4 COX19 ERBB3 IKZF3 KALRN MARK3 NUP88 ANKLE2 GH1 CMIP FDFT1 MCM3AP C3 HFM1 MICAL3 PREX1 | 2.66e-03 | 1464 | 147 | 16 | EFO_0004587 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.67e-03 | 276 | 147 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | Pre-Eclampsia | 2.83e-03 | 16 | 147 | 2 | C0032914 | |
| Disease | Antibody Deficiency Syndrome | 3.19e-03 | 17 | 147 | 2 | C0003257 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 3.19e-03 | 17 | 147 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 3.30e-03 | 122 | 147 | 4 | EFO_0009264, EFO_0010724 | |
| Disease | Insulin Resistance | 3.37e-03 | 60 | 147 | 3 | C0021655 | |
| Disease | polycystic ovary syndrome | 3.37e-03 | 60 | 147 | 3 | EFO_0000660 | |
| Disease | Insulin Sensitivity | 3.37e-03 | 60 | 147 | 3 | C0920563 | |
| Disease | body fat distribution | 3.49e-03 | 202 | 147 | 5 | EFO_0004341 | |
| Disease | Allergic Reaction | 3.87e-03 | 63 | 147 | 3 | C1527304 | |
| Disease | Hypersensitivity | 4.04e-03 | 64 | 147 | 3 | C0020517 | |
| Disease | Calcium channel blocker use measurement | 4.36e-03 | 213 | 147 | 5 | EFO_0009930 | |
| Disease | maximal midexpiratory flow rate | 4.42e-03 | 20 | 147 | 2 | EFO_0004313 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 4.42e-03 | 20 | 147 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | COVID-19 (is_implicated_in) | 4.86e-03 | 21 | 147 | 2 | DOID:0080600 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLYERCEVVMGNLEI | 51 | P21860 | |
| REYKCDVLMRENEAL | 46 | P56851 | |
| KEQYCIRKVRPSEEM | 201 | Q9Y2D5 | |
| DDDEAMLQKRIRYVV | 386 | Q86XL3 | |
| EYQRLNEVRCKMESE | 76 | Q8NFR7 | |
| DFRIKQCTRVTMDQL | 371 | P12821 | |
| MSDRYLEQRISIKFC | 1 | Q3ZCU0 | |
| KVQVERMREVNSRCY | 161 | Q9NWN3 | |
| RIIYDRKFLMECRNS | 51 | Q13541 | |
| STDVGKRMYEQLCDR | 611 | Q8IY22 | |
| KRMYEQLCDRQRELK | 616 | Q8IY22 | |
| KNTMILEICTRYRGD | 1381 | P01024 | |
| EITVFREDLVNKMCR | 411 | P56282 | |
| KLYEAIMREDCTTIE | 31 | A6NGH8 | |
| RVMLDYVDQVRICSK | 496 | A6NK59 | |
| VRVCQALMDYKVFEA | 96 | Q96QD5 | |
| LCMDTSLDVYRKLIE | 146 | Q9Y394 | |
| VYCRVIREKNLCQDM | 1056 | Q8TE56 | |
| ITDVKLQDAGVYRCM | 101 | Q9NZQ7 | |
| VYCRVIREKNLCQDM | 1171 | Q8TE59 | |
| RIQDMKECPEYTVRQ | 221 | P35236 | |
| LIDYARMREVCDEVK | 231 | P34897 | |
| INPLCIEMYADKESR | 2211 | O00763 | |
| YCLAVVEVVRRKMFI | 496 | Q8TDY2 | |
| MLITVYCVRRDLSEV | 1 | Q8WTU0 | |
| DLDKELNNYIMRCRE | 171 | Q9Y2X3 | |
| LKCMQRFREIIDQFE | 296 | Q9NUD7 | |
| RQMLRKSREYDCQIL | 756 | Q96AA8 | |
| KSREYDCQILQERME | 761 | Q96AA8 | |
| ELTERECIKYMRQIS | 1556 | Q15746 | |
| FCQKRVYVMERLSAE | 766 | Q7RTP6 | |
| IKEYACTAVDMISRR | 541 | P43304 | |
| VRYRMEASCLELALE | 16 | P81274 | |
| IATYRKLLEGEECRM | 431 | Q86Y46 | |
| EVLEKCMRLSYHQRI | 451 | Q09161 | |
| MTCARVRVYERKKED | 1236 | Q8IWI9 | |
| RVKQVCGDYLLSRMD | 116 | Q9Y6Y0 | |
| MEQLVEKACFRDYQR | 1106 | Q86WG5 | |
| SEEARKRLEYQMCLA | 11 | Q6UWE0 | |
| KLYVRRVFIMDSCDE | 296 | Q58FF7 | |
| QRMRADEIKDAIYVT | 466 | O60303 | |
| MSYCRQEGKDRIIFV | 1 | Q8N4Q1 | |
| VRTKMVYCKIDQTQR | 316 | Q7L2H7 | |
| CPEKERYMRETRSQL | 641 | O60318 | |
| EKFDLRTTMLYICER | 1456 | Q9NRD8 | |
| AEKYQTVIADICRRM | 136 | P37268 | |
| ENMECRDTTRYCEKV | 1726 | Q8N6G6 | |
| CRKESKEYLECRMER | 51 | Q49B96 | |
| NPKLCVSEIYRMEEV | 451 | P08069 | |
| RYMAAIILSEKQCRD | 131 | Q9BX97 | |
| VSKNYRSVIRACMEE | 101 | Q9BW27 | |
| VMKLACDDIRVNVVY | 186 | Q8TCB6 | |
| IRHSECIYRVTMEKL | 421 | Q9Y233 | |
| DRYRADLKAVREKCM | 301 | Q6NV75 | |
| CKFALMNRETSERVV | 2191 | O60229 | |
| RVIVMLYNKVCDIVS | 1381 | Q6KC79 | |
| CIIAMDRLTKDTYRV | 81 | Q6IPT4 | |
| VMADKELYRACAVEV | 131 | Q8WX92 | |
| LVVSKELRMYDERAQ | 311 | Q9P2J3 | |
| KTCMYRSEQEELRDK | 556 | Q8N9T8 | |
| EKVTCERRYIPDAMN | 326 | P42704 | |
| IEKDCAVYVGRMERV | 636 | Q96RT7 | |
| DLNRVLEEMRCQYET | 261 | Q92764 | |
| CRGFLARVEYQKMVE | 796 | P12882 | |
| QKMVERRESIFCIQY | 806 | P12882 | |
| CEYISEMLLRNKSVR | 796 | Q96MN2 | |
| TQKRYEEVMVKCINA | 561 | Q05C16 | |
| VMKLACSDNRIDVIY | 186 | Q8NGJ7 | |
| VMKLACSDNRIDVIY | 186 | Q8NGJ6 | |
| LYTVAMSDRKCVELV | 131 | Q8NH18 | |
| SRCTYVVLDEADRMI | 541 | Q9BUQ8 | |
| IGRQLAMYECKVIAE | 206 | Q9Y5U4 | |
| DTVYRVCDLIMTAIK | 1456 | Q7Z6Z7 | |
| DKYIQMLACRDTVES | 676 | A2PYH4 | |
| IQNGAREDCREMKIY | 576 | P08648 | |
| REDCREMKIYLRNES | 581 | P08648 | |
| QEMDERRTIKLSECY | 216 | Q5T0N5 | |
| YMDCNLIARRQTDEK | 186 | Q14993 | |
| VVVYCDRDTQLARLM | 131 | Q8WVC6 | |
| DPDRYQMVICRLQKE | 456 | Q7L775 | |
| ETLEQQKRICEMAAY | 1076 | P53621 | |
| RYLGLMRCDKVNEVT | 646 | Q9UF56 | |
| VLQDCKRTLERAYQM | 676 | Q9UF56 | |
| EIDYTLCFRVRKMID | 1121 | Q9P0X4 | |
| KMRYLEVSEPQDIEC | 181 | O15371 | |
| YDEISQLRLVCKRMD | 81 | Q9NVF7 | |
| VKMDRSLEYQPVECA | 271 | Q96CU9 | |
| SYEDMREVVCVKRLR | 466 | P36894 | |
| YIIGMLERCTDKLER | 896 | O75165 | |
| MREIRKVLDANNCDY | 676 | P27448 | |
| DREKCDTYQLIMEVR | 311 | Q08554 | |
| KIDLEVRSLETCMYD | 856 | Q14204 | |
| EQIDLIRRMCASYSE | 151 | Q9H4A9 | |
| EKIVRLMSAECTYDL | 381 | Q8NFN8 | |
| KVMKYERCQADQARL | 316 | Q7Z4H7 | |
| KMQLERYRVEYEALC | 101 | Q8IY31 | |
| IKLYVRRVFIMDNCE | 361 | P07900 | |
| MLLTVYCVRRDLSEV | 1 | Q5TDH0 | |
| EDLCRKSAIIETYVM | 741 | Q4V328 | |
| VINKEGEVMDVYRCD | 441 | Q9UKT9 | |
| VECKMNNIVSTRIYE | 116 | Q0Z7S8 | |
| YMLVAKCLREEQETG | 71 | W6CW81 | |
| IDTACEILYERMKSL | 786 | Q14562 | |
| VDLNKILEDMRCQYE | 256 | O76013 | |
| MAEREGVVDIYNCVK | 1101 | Q15262 | |
| SYCREERKSLREMAE | 606 | Q99567 | |
| MIRAMDTLRIQYVCE | 86 | O95837 | |
| AVIGEYLCMRTELKE | 131 | Q8N2H4 | |
| CTVSLTRYRVMIKEE | 231 | Q9NUQ6 | |
| RVVRENKEGCYTNRM | 211 | Q9NUV9 | |
| TCSEMQQKVELLRYE | 1501 | Q8N4C6 | |
| TVERCQELYRKYEMQ | 2676 | Q96Q15 | |
| ELEDIMSKGVRLYCR | 506 | Q8TCU6 | |
| VELCRDVAQYRLMKE | 326 | Q969V4 | |
| RKMMERRESIFCIQY | 806 | Q9Y623 | |
| EFQKMVQRRESIFCI | 801 | P11055 | |
| CLQQYKRRQEMADEI | 1261 | Q8N3P4 | |
| KRRQEMADEIIVFSC | 1266 | Q8N3P4 | |
| EDYRVCMDFNIIRKD | 331 | P41252 | |
| EMQQKGCLERRYDTV | 76 | Q9HAS3 | |
| DTNVLVYIKRRLAMC | 291 | Q9NRC1 | |
| LLIQTMCEKSYIEAR | 376 | Q7Z745 | |
| DKRVQTMNEFLTCIR | 296 | Q96J65 | |
| RGTTVYLCEKRIDMV | 526 | Q9Y2L1 | |
| RNASYCDKMSIELRV | 111 | P27930 | |
| IEEMNFLRRYKCSSD | 76 | Q92478 | |
| MDKVETFLRIVQCRS | 196 | P01242 | |
| VDMLCKRIADISQVY | 111 | P60900 | |
| ESEYSMRLRLLNEEC | 106 | Q8N7C3 | |
| RNMADRYERLQKICS | 286 | Q9NRF8 | |
| DCLRDAMVRDYVRQT | 116 | P43403 | |
| ECLDTTQRKLYRDVM | 21 | Q8NDQ6 | |
| CKRVFQEEDLRQIFM | 186 | Q9C0E2 | |
| TERTYVKDLNCLMER | 1051 | Q13009 | |
| VCESEIRAYMRQVLE | 1691 | Q15772 | |
| MDEINYAKEEACRLR | 291 | Q9P246 | |
| MERVESQVLKRNECY | 786 | Q6ZVD7 | |
| DDIRCKRYTLRKVMV | 311 | Q08AE8 | |
| SRSMEYVQRQISKEC | 206 | Q7Z699 | |
| KPENILMCVDDAYVR | 216 | P78362 | |
| EAVAEKMLQYRRDTA | 11 | Q9NSY2 | |
| LKELNIDMEVRSYDC | 731 | Q9HCK1 | |
| LLRMCRYVKISTETE | 611 | Q9Y4E8 | |
| MDKVETFLRIVQCRS | 196 | P01241 | |
| MVRVLTVIKEYINEC | 851 | O00507 | |
| DRCQSVVEFIKRAIM | 466 | O14512 | |
| KDTERMYLCLSQERI | 291 | Q06330 | |
| IRYRENIASLMDKCF | 276 | Q99986 | |
| REAEASRRCMELEKY | 2041 | Q8IUG5 | |
| SRRCMELEKYVEELA | 2046 | Q8IUG5 | |
| LQVEVDSSQKECRMY | 626 | Q9H6N6 | |
| KREYTTICRLESFME | 156 | O75569 | |
| AMYLDCISDLRQKEI | 276 | O60290 | |
| RDASQCYVKMVCLRE | 441 | Q9NNW7 | |
| CLDLEQRDLYRDVML | 21 | Q6PG37 | |
| TYRDICKNMVLAERC | 491 | Q9Y2L5 | |
| RCVLRETNMASRYEK | 196 | P0C1S8 | |
| LDEAQRCLYRDVMLE | 31 | Q13106 | |
| VEVYMDCKGRSVDVL | 591 | Q8TE54 | |
| NERILAMRAEEKYEI | 131 | Q2TAA8 | |
| YLEMKDSEIRQIECD | 591 | Q96FV9 | |
| IQTEKAYVRDLRECM | 1301 | O75962 | |
| CQARLVMYIERDSRK | 771 | Q96C45 | |
| MVQIRLEDRCYPVSK | 6 | Q9P2K6 |